Oncternal Therapeutics (ONCT) P/E (2020 - 2026)
Oncternal Therapeutics (ONCT) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Oncternal Therapeutics (ONCT) P/E is -0.05. You can export chart.
P/E
Annual P/E change of Oncternal Therapeutics (ONCT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.05 | N/A |
| 2025 | -0.05 | N/A |
| 2024 | -0.05 | -93.85% |
| 2023 | -0.73 | -41.23% |
| 2022 | -1.24 | -65.17% |
| 2021 | -3.57 | -74.90% |
| 2020 | -14.24 | N/A |
Comparison Oncternal Therapeutics (ONCT) P/E with competitors
Oncternal Therapeutics (ONCT) P/E is -0.05.